Per Adacel 0.5 mL Diphtheria toxoid (reduced), tetanus toxoid, adsorbed acellular pertussis vaccine. Per Adacel Polio 0.5 mL Tetanus toxoid, diphtheria toxoid (reduced), adsorbed acellular pertussis vaccine w/ inactivated poliomyelitis virus type 1, 2, 3 vaccine
Indications/Uses
Adacel Active booster immunization for the prevention of tetanus, diphtheria & pertussis in persons ≥4 yr. Passive protection against pertussis in early infancy following maternal immunization during pregnancy. Alternative for the 5th dose of tetanus, diphtheria & acellular pertussis vaccine (DTaP) in childn 4-6 yr, concomitantly w/ inactivated poliomyelitis vaccine. Tetanus prophylaxis in wound management. Adacel Polio Active booster immunization for the prevention of tetanus, diphtheria, pertussis & poliomyelitis in persons ≥4 yr. May be an alternative for the 5th dose of diphtheria, tetanus, acellular pertussis & inactivated poliomyelitis vaccine (DTaP-IPV) in childn 4-6 yr. Tetanus prophylaxis in wound management.
Adacel/Adacel PolioAdult & childn ≥4 yr 1 single dose inj (0.5 mL) IM, preferably on deltoid muscle. Management of tetanus-prone wounds Persons who have completed primary immunization against tetanus & who sustain wounds that are minor & uncontaminated, should receive a booster dose of a tetanus toxoid-containing prep if they have not received tetanus toxoid w/in the preceding 10 yr. For tetanus-prone wounds, a booster is appropriate if the patient has not received a tetanus toxoid-containing prep w/in the preceding 5 yr. Adacel Redosing at 5-10 yr intervals to boost immunity. Pregnant women Administer during the 2nd or 3rd trimester to provide passive protection of infants against pertussis.
Do not administer intravascularly, intradermally, SC or into the buttocks. Postpone vaccination in case of acute or febrile illness. Risk of hematoma in patients w/ any bleeding disorders eg, haemophilia or thrombocytopenia, or those on anticoagulant therapy. Hypersensitivity reactions may occur. Do not administer in patients w/ progressive or unstable neurological disorder, uncontrolled epilepsy, or progressive encephalopathy until a treatment regimen has been established, the condition has stabilized & the benefit clearly outweighs the risk. If Guillain-Barré syndrome occurred w/in 6 wk of receipt of prior vaccine containing tetanus toxoid, carefully consider potential benefits & possible risks before vaccination. Pregnancy & lactation. Immunocompromised patients. Adacel Not for childn <4 yr.
J07CA02 - diphtheria-pertussis-poliomyelitis-tetanus ; Belongs to the class of combined bacterial and viral vaccines. J07AJ52 - pertussis, purified antigen, combinations with toxoids ; Belongs to the class of pertussis bacterial vaccines.
Sign Out
ed6fea94-9211-4426-8930-a97000ecebbd.GIF)
